Purdue Pharma, the maker of opioid OxyContin, reached a tentative deal Wednesday over its role in the nation’s opioid crisis. Sources say that Stamford, Connecticut-based Purdue will pay up to $12 billion over time and that the Sackler family will give up control of the company.
Consumer
OxyContin maker Purdue Pharma could file for bankruptcy as early as today: sources
More Videos
-
Business Matters: November home sales down almost 11% annually as market hits ‘holding pattern’
-
The Morning Show: December 12
-
‘It was just frustrating’: Passengers stranded on Via Rail after mechanical issue
-
Sephora Canada drops more hints about what your friends really want for the holidays
-
Business Matters: Half of Canadians support a new pipeline between Alberta and B.C.
-
Health Matters: Canada approves drug for postpartum depression
You are viewing an Accelerated Mobile Webpage.
View Original Article